Innovita Biological Technology Co., Ltd. (SHA:688253)

Market Cap	4.69B +14.5%
Revenue (ttm)	422.03M -32.1%
Net Income	146.04M -40.8%
EPS	1.07 -40.9%
Shares Out	134.87M
PE Ratio	32.52
Forward PE	27.62
Dividend	0.56 (1.61%)
Ex-Dividend Date	n/a

Volume	1,276,931
Average Volume	1,570,752
Open	33.30
Previous Close	33.64
Day's Range	33.30 - 34.89
52-Week Range	27.56 - 40.00
Beta	1.00
RSI	49.15
Earnings Date	Apr 28, 2026

About SHA:688253

Innovita Biological Technology Co., Ltd., a biopharmaceutical enterprise, engages in the research and development, production and sales of POCT rapid diagnostic products. It offers covid-19 test, respiratory disease test, gastrointestinal disease test, fertility test, tropical disease test, and hepatitis test. The company was founded in 2006 and is based in Beijing, China.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2006
• Employees: 558
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688253

Financial Performance

In 2025, SHA:688253's revenue was 422.03 million, a decrease of -32.08% compared to the previous year's 621.39 million. Earnings were 146.04 million, a decrease of -40.84%.